359 related articles for article (PubMed ID: 8535945)
1. Immunotherapy in multiple sclerosis, Part 2.
Becker CC; Gidal BE; Fleming JO
Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in multiple sclerosis, Part 1.
Becker CC; Gidal BE; Fleming JO
Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866
[TBL] [Abstract][Full Text] [Related]
3. Immunologic therapy for secondary and primary progressive multiple sclerosis.
Myers LW
Curr Neurol Neurosci Rep; 2001 May; 1(3):286-93. PubMed ID: 11898531
[TBL] [Abstract][Full Text] [Related]
4. What is new in the treatment of multiple sclerosis?
Weinstock-Guttman B; Jacobs LD
Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827
[TBL] [Abstract][Full Text] [Related]
5. Immunologic therapy for relapsing-remitting multiple sclerosis.
MacLean HJ; Freedman MS
Curr Neurol Neurosci Rep; 2001 May; 1(3):277-85. PubMed ID: 11898530
[TBL] [Abstract][Full Text] [Related]
6. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
7. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
8. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
Pender MP; Wolfe NP
Intern Med J; 2002 Nov; 32(11):554-63. PubMed ID: 12412939
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness.
Clegg A; Bryant J
Expert Opin Pharmacother; 2001 Apr; 2(4):623-39. PubMed ID: 11336612
[TBL] [Abstract][Full Text] [Related]
10. Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
Clegg A; Bryant J; Milne R
Health Technol Assess; 2000; 4(9):i-iv, 1-101. PubMed ID: 10944743
[No Abstract] [Full Text] [Related]
11. Non-specific immunosuppressants in the treatment of multiple sclerosis.
Confavreux C; Vukusic S
Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
[TBL] [Abstract][Full Text] [Related]
13. Newer versus older treatments for relapsing-remitting multiple sclerosis.
Weinstock-Guttman B; Cohen JA
Drug Saf; 1996 Feb; 14(2):121-30. PubMed ID: 8852526
[TBL] [Abstract][Full Text] [Related]
14. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
15. Drug Insight: interferon treatment in multiple sclerosis.
Marrie RA; Rudick RA
Nat Clin Pract Neurol; 2006 Jan; 2(1):34-44. PubMed ID: 16932519
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Le Page E; Leray E; Taurin G; Coustans M; Chaperon J; Morrissey SP; Edan G
J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):52-6. PubMed ID: 17846110
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
Massacesi L; Tramacere I; Amoroso S; Battaglia MA; Benedetti MD; Filippini G; La Mantia L; Repice A; Solari A; Tedeschi G; Milanese C
PLoS One; 2014; 9(11):e113371. PubMed ID: 25402490
[TBL] [Abstract][Full Text] [Related]
18. Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG].
Rieckmann P; Toyka KV
Eur Neurol; 1999; 42(3):121-7. PubMed ID: 10529535
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
Stuart WH
Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
[TBL] [Abstract][Full Text] [Related]
20. The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Reggio E; Nicoletti A; Fiorilla T; Politi G; Reggio A; Patti F
J Neurol; 2005 Oct; 252(10):1255-61. PubMed ID: 15940386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]